A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease

NCT05432167 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Uncontrolled Hypertension
Chronic Kidney Diseases

Interventions

DRUG: CIN-107
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]